Can Superoxide Anions Predict the Malignant Potential of Carotid body Tumor? - A Pilot Study

[1]  T. Münzel,et al.  Comparison of Mitochondrial Superoxide Detection Ex Vivo/In Vivo by mitoSOX HPLC Method with Classical Assays in Three Different Animal Models of Oxidative Stress , 2019, Antioxidants.

[2]  W. Young,et al.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years , 2017, The Journal of clinical endocrinology and metabolism.

[3]  Ellen T. Arena,et al.  Quantitating the cell: turning images into numbers with ImageJ , 2017, Wiley interdisciplinary reviews. Developmental biology.

[4]  S. Satpathy,et al.  Unit Cost Analysis of PET-CT at an Apex Public Sector Health Care Institute in India , 2017, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

[5]  Hong Zhu,et al.  MitoSOX-Based Flow Cytometry for Detecting Mitochondrial ROS. , 2016, Reactive oxygen species.

[6]  E. Hefnawy,et al.  Carotid body tumors: a review of 25 years experience in diagnosis and management of 56 tumors. , 2014, Annals of vascular diseases.

[7]  J. Adler,et al.  Current approaches and recent developments in the management of head and neck paragangliomas. , 2014, Endocrine reviews.

[8]  J. Laredo,et al.  Malignant head/neck paragangliomas. Comparative study. , 2014, European annals of otorhinolaryngology, head and neck diseases.

[9]  A. Thakar,et al.  68Ga-DOTANOC PET/CT for Baseline Evaluation of Patients with Head and Neck Paraganglioma , 2013, The Journal of Nuclear Medicine.

[10]  E. Baudin,et al.  Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma , 2013, Current Oncology Reports.

[11]  T. Cohnert,et al.  Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[12]  Takamasa Ishii,et al.  Model animals for the study of oxidative stress from complex II. , 2013, Biochimica et biophysica acta.

[13]  S. Roman,et al.  Malignant pheochromocytoma and paraganglioma: A population level analysis of long‐term survival over two decades , 2013, Journal of surgical oncology.

[14]  F. Beuschlein,et al.  Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma , 2013, Annals of clinical biochemistry.

[15]  M. Kupferman,et al.  Genetic Testing in Head and Neck Paraganglioma: Who, What, and Why? , 2011, Journal of Neurological Surgery—Part B.

[16]  Y. Suputtamongkol,et al.  Application of ImageJ program to the enumeration of Orientia tsutsugamushi organisms cultured in vitro , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  A. Malhotra,et al.  Imaging carotid body chemodectomas with ⁶⁸Ga-DOTA-NOC PET-CT. , 2012, The British journal of radiology.

[18]  P. Levillain,et al.  Malignant pheochromocytoma: new malignancy criteria , 2012, Langenbeck's Archives of Surgery.

[19]  H. Lehnert,et al.  Metastatic paraganglioma. , 2010, Seminars in oncology.

[20]  J. Wieneke,et al.  Paraganglioma: Carotid Body Tumor , 2009, Head and neck pathology.

[21]  Okio Hino,et al.  A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. , 2005, Cancer research.

[22]  E. Myers,et al.  Etiopathogenesis and clinical presentation of carotid body tumors , 2002, Microscopy research and technique.

[23]  G. Bisgard,et al.  Chronic hypoxia‐induced morphological and neurochemical changes in the carotid body , 2002, Microscopy research and technique.

[24]  N. Rich,et al.  Malignant carotid body tumor: a case report. , 2000, Journal of vascular surgery.